Paloma Partners’s Emergent Biosolutions EBS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-63,790
| Closed | -$435K | – | 965 |
|
|
2024
Q2 | $435K | Buy |
+63,790
| New | +$435K | 0.01% | 428 |
|
|
2020
Q3 | – | Sell |
-7,692
| Closed | -$608K | – | 1943 |
|
|
2020
Q2 | $608K | Buy |
+7,692
| New | +$608K | 0.01% | 1015 |
|
|
2020
Q1 | – | Sell |
-4,480
| Closed | -$242K | – | 1281 |
|
|
2019
Q4 | $242K | Sell |
4,480
-4,997
| -53% | -$270K | ﹤0.01% | 1583 |
|
|
2019
Q3 | $495K | Buy |
9,477
+4,827
| +104% | +$252K | 0.01% | 900 |
|
|
2019
Q2 | $225K | Buy |
4,650
+34
| +0.7% | +$1.65K | ﹤0.01% | 1231 |
|
|
2019
Q1 | $233K | Buy |
+4,616
| New | +$233K | 0.01% | 1114 |
|
|
2017
Q2 | – | Sell |
-12,586
| Closed | -$366K | – | 1686 |
|
|
2017
Q1 | $366K | Sell |
12,586
-14,683
| -54% | -$427K | ﹤0.01% | 1219 |
|
|
2016
Q4 | $895K | Buy |
27,269
+14,733
| +118% | +$484K | 0.01% | 837 |
|
|
2016
Q3 | $395K | Sell |
12,536
-25,439
| -67% | -$802K | ﹤0.01% | 1049 |
|
|
2016
Q2 | $1.07M | Buy |
37,975
+18,736
| +97% | +$526K | 0.01% | 755 |
|
|
2016
Q1 | $699K | Buy |
+19,239
| New | +$699K | 0.01% | 766 |
|